SignatureFD’s BioNTech BNTX Stock Holding History

SignatureFD’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Sell	1,132 -11	-1%	-$1.03K	﹤0.01%	1413
2026 Q1	$102K	Buy	+1,143	New	+$117K	﹤0.01%	1341
2025 Q2	–	Sell	-1	Closed	-$59	–	3280
2025 Q1	$59	Buy	+1	New	+$112	﹤0.01%	3284
2024 Q4	–	Sell	-5	Closed	-$594	–	3320
2024 Q3	$594	Buy	+5	New	+$460	﹤0.01%	3072
2024 Q2	–	Sell	-2	Closed	-$185	–	3138
2024 Q1	$185	Hold	2	–	–	﹤0.01%	3102
2023 Q4	$211	Hold	2	–	–	﹤0.01%	3055
2023 Q3	$217	Hold	2	–	–	﹤0.01%	3086
2023 Q2	$216	Sell	2 -375	-99%	-$42.2K	﹤0.01%	3131
2023 Q1	$47K	Buy	377 +375	+18,750%	+$51.5K	﹤0.01%	1420
2022 Q4	$300	Hold	2	–	–	﹤0.01%	3160
2022 Q3	$0	Hold	2	–	–	﹤0.01%	3119
2022 Q2	$0	Hold	2	–	–	﹤0.01%	3125
2022 Q1	$0	Buy	+2	New	+$336	﹤0.01%	3150
2021 Q4	–	Sell	-629	Closed	-$172K	–	3117
2021 Q3	$172K	Buy	+629	New	+$200K	0.01%	749

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

SignatureFD's BNTX Position: Q2 2026 in Review

SignatureFD reduced its BioNTech (BNTX) stake by 0.96% in Q2 2026, selling an estimated $1.03K and leaving 1,132 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

SignatureFD first reported a position in BNTX in Q3 2021 and has held it in 14 quarters since. The position peaked at $172K in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

SignatureFD held 1,132 shares of BioNTech worth $105K as of Q2 2026.
SignatureFD sold 11 BioNTech shares in Q2 2026, an estimated $1.03K.
BioNTech made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1413 holding.
SignatureFD first reported a position in BioNTech in Q3 2021 and has held it in 14 quarters since.
SignatureFD's BioNTech position peaked at $172K in Q3 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.